Anne Møller Nielsen (Anne M Nielsen)

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 2

Top Topics

Randomized Controlled Trial

Top Venues

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Yuichiro Yamada, Daisuke Yabe, Christin Løth Hertz, Hiroshi Horio, Jiro Nakamura, Anne Møller Nielsen, Yutaka Seino
Efficacy and safety of oral semaglutide by baseline age in Japanese patients with type 2 diabetes: A subgroup analysis of the PIONEER 9 and 10 Japan trials. Diabetes, obesity & metabolism (2021)
Wenying Yang, Jianhua Ma, Tianpei Hong, Ming Liu, Heng Miao, Yongde Peng, Changjiang Wang, Xiangjin Xu, Tao Yang, Anne Møller Nielsen, Lili Pan, Weihong Liu, Weigang Zhao
Efficacy and safety of insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Chinese adults with type 2 diabetes: A phase III, open-label, 2:1 randomized, treat-to-target trial. Diabetes, obesity & metabolism 21 (7) (2019)